Anani Badjé

454 total citations
22 papers, 278 citations indexed

About

Anani Badjé is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Anani Badjé has authored 22 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 9 papers in Virology and 9 papers in Epidemiology. Recurrent topics in Anani Badjé's work include HIV/AIDS Research and Interventions (13 papers), HIV Research and Treatment (9 papers) and HIV-related health complications and treatments (6 papers). Anani Badjé is often cited by papers focused on HIV/AIDS Research and Interventions (13 papers), HIV Research and Treatment (9 papers) and HIV-related health complications and treatments (6 papers). Anani Badjé collaborates with scholars based in France, Ivory Coast and United States. Anani Badjé's co-authors include Xavier Anglaret, Raoul Moh, Christine Danel, Delphine Gabillard, Serge Eholié, Kévin Jean, Gérard Menan Kouamé, Éric Ouattara, Serge Eholié and Didier Koumavi Ekouévi and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Anani Badjé

20 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anani Badjé France	8	205	150	77	65	42	22	278
Éric Ouattara France	11	230 1.1×	151 1.0×	71 0.9×	70 1.1×	37 0.9×	23	337
Nicolas Durier Thailand	11	163 0.8×	227 1.5×	43 0.6×	94 1.4×	73 1.7×	22	371
JM Miró Spain	8	199 1.0×	135 0.9×	84 1.1×	118 1.8×	76 1.8×	14	355
Silvia Carradori Italy	10	310 1.5×	122 0.8×	108 1.4×	144 2.2×	31 0.7×	13	398
L. Fonquernie France	10	88 0.4×	168 1.1×	38 0.5×	40 0.6×	99 2.4×	23	259
Julia del Amo Spain	9	232 1.1×	170 1.1×	142 1.8×	69 1.1×	76 1.8×	21	327
Luigi Pusterla Italy	7	245 1.2×	92 0.6×	144 1.9×	138 2.1×	27 0.6×	8	366
Girish Prajapati United States	10	249 1.2×	179 1.2×	172 2.2×	95 1.5×	124 3.0×	25	436
Paulo Ricardo de Alencastro Brazil	10	198 1.0×	88 0.6×	193 2.5×	114 1.8×	31 0.7×	17	333
Kerunne S. Ketlogetswe United States	8	174 0.8×	159 1.1×	124 1.6×	108 1.7×	9 0.2×	10	334

Countries citing papers authored by Anani Badjé

Since Specialization

Citations

This map shows the geographic impact of Anani Badjé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anani Badjé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anani Badjé more than expected).

Fields of papers citing papers by Anani Badjé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anani Badjé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anani Badjé. The network helps show where Anani Badjé may publish in the future.

Co-authorship network of co-authors of Anani Badjé

This figure shows the co-authorship network connecting the top 25 collaborators of Anani Badjé. A scholar is included among the top collaborators of Anani Badjé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anani Badjé. Anani Badjé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sturny-Leclère, Aude, Anani Badjé, Dea Garcia‐Hermoso, et al.. (2025). Histoplasma Antigenuria Prevalence in Patients With Advanced HIV Disease in Côte d’Ivoire: A Prospective Trial Ancillary Study. Clinical Infectious Diseases. 81(5). 950–958. 1 indexed citations

Coffié, Patrick, et al.. (2022). Community Health Workers. Reinforcement of an Outreach Strategy in Rural Areas Aimed at Improving the Integration of HIV, Tuberculosis and Malaria Prevention, Screening and Care Into the Health Systems. “Proxy-Santé” Study. Frontiers in Public Health. 10. 801762–801762. 5 indexed citations

Jean, Kévin, Delphine Gabillard, Anani Badjé, et al.. (2022). Association of cellular HIV-1 DNA and virological success of antiretroviral treatment in HIV-infected sub-Saharan African adults. BMC Infectious Diseases. 22(1). 1 indexed citations

Gabillard, Delphine, Gérard Menan Kouamé, Raoul Moh, et al.. (2022). Plasma sVCAM‐1, antiretroviral therapy and mortality in HIV‐1‐infected West African adults. HIV Medicine. 23(7). 717–726. 4 indexed citations

Kouamé, Gérard Menan, Delphine Gabillard, Raoul Moh, et al.. (2021). Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4⁺ cell counts. Antiviral Therapy. 26(1-2). 25–33. 4 indexed citations

Blanc, F.–X., Anani Badjé, Maryline Bonnet, et al.. (2020). Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults. New England Journal of Medicine. 382(25). 2397–2410. 23 indexed citations

Gabillard, Delphine, Raoul Moh, Arlette Emième, et al.. (2020). Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts. EBioMedicine. 56. 102815–102815. 7 indexed citations

Gabillard, Delphine, Catherine Dunyach‐Remy, Kévin Jean, et al.. (2020). Association of Plasma Soluble Vascular Cell Adhesion Molecule-1 and sCD14 With Mortality in HIV-1–Infected West African Adults With High CD4 Counts. JAIDS Journal of Acquired Immune Deficiency Syndromes. 86(1). 138–145. 4 indexed citations

Ross, Jennifer M., Anani Badjé, Molebogeng X. Rangaka, et al.. (2020). Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data. The Lancet HIV. 8(1). e8–e15. 32 indexed citations

10.

Jean, Kévin, Delphine Gabillard, Raoul Moh, et al.. (2020). Association between Cellular HIV-1 DNA Level and Mortality in HIV-1 Infected African Adults Starting ART with High CD4 Counts. SSRN Electronic Journal. 2 indexed citations

11.

Mohareb, Amir M., Gérard Menan Kouamé, Audrey Gabassi, et al.. (2020). Mortality in relation to hepatitis B virus (HBV) infection status among HIV‐HBV co‐infected patients in sub‐Saharan Africa after immediate initiation of antiretroviral therapy. Journal of Viral Hepatitis. 28(4). 621–629. 5 indexed citations

12.

Badjé, Anani, Kévin Jean, Jean-Baptiste Anzouan-Kacou, et al.. (2018). Dissection aortique anévrismale chez un adulte infecté par le VIH-1 dans le cadre d’un syndrome de reconstitution immune avec tuberculose. Pan African Medical Journal. 31. 10–10.

13.

Gabillard, Delphine, Raoul Moh, Anani Badjé, et al.. (2017). High correlation between Framingham equations with BMI and with lipids to estimate cardiovascular risks score at baseline in HIV-infected adults in the Temprano trial, ANRS 12136 in Côte d’Ivoire. PLoS ONE. 12(6). e0177440–e0177440. 11 indexed citations

14.

Boyd, Anders, Raoul Moh, Anani Badjé, et al.. (2017). Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)–Coinfected Patients With High HBV Replication. Clinical Infectious Diseases. 66(1). 112–120. 45 indexed citations

15.

Guéhi, Calixte, Anani Badjé, Delphine Gabillard, et al.. (2016). High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial. AIDS Research and Therapy. 13(1). 12–12. 53 indexed citations

16.

Jean, Kévin, Christine Danel, Raoul Moh, et al.. (2016). Early antiretroviral therapy initiation in west Africa has no adverse social consequences. AIDS. 30(10). 1677–1682. 2 indexed citations

17.

Eholié, Serge, Anani Badjé, Gérard Menan Kouamé, et al.. (2016). Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question. AIDS Research and Therapy. 13(1). 27–27. 56 indexed citations

18.

Jean, Kévin, Marie‐Claude Boily, Christine Danel, et al.. (2016). What Level of Risk Compensation Would Offset the Preventive Effect of Early Antiretroviral Therapy? Simulations From the TEMPRANO Trial. American Journal of Epidemiology. 184(10). 755–760. 1 indexed citations

19.

Danel, Christine, Mathieu Kabran, André Inwoley, et al.. (2014). Quantiferon-TB Gold: Performance for Ruling out Active Tuberculosis in HIV-Infected Adults with High CD4 Count in Côte d'Ivoire, West Africa. PLoS ONE. 9(10). e107245–e107245. 7 indexed citations

20.

Jean, Kévin, Delphine Gabillard, Raoul Moh, et al.. (2014). Decrease in sexual risk behaviours after early initiation of antiretroviral therapy: a 24‐month prospective study in Côte d'Ivoire. Journal of the International AIDS Society. 17(1). 18977–18977. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact